Dr. Reddy's Laboratories Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Dec 3, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
DRL filed a 6-K, just routine compliance stuff.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 3, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events but serves as a routine submission to the SEC.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is complying with its reporting obligations as a foreign private issuer with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing and does not contain new material information or financial disclosures.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001227 (filing_id) — Accession Number
- 20241203 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Ltd. to submit information to the SEC.
When was this Form 6-K filed?
This Form 6-K was filed on December 3, 2024.
What is the company's principal executive office address?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
The filing indicates that Dr. Reddy's Laboratories files annual reports under cover of Form 20-F.
Does this filing contain specific financial results or material events?
Based on the provided text, this filing appears to be a routine submission and does not detail specific financial results or material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-12-03 06:15:41
Filing Documents
- drr0703_6k.htm (6-K) — 14KB
- drr0703_ex99-1.htm (EX-99.1) — 9KB
- drr0703_ex99-1img01.jpg (GRAPHIC) — 8KB
- drr0703_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-001227.txt ( ) — 40KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: December 3, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3